Drugs / HY01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04961099 | Jun → Oct 2021 | sudden sensorineural hearing loss | Heyu (Suzhou) Pharmaceutical Technology Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HY01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04961099 ↗ |